New adaptive clinical trial offers new hope for progressive multiple sclerosis
The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
Managing multiple sclerosis, Griffith University Alumnus Gavin Jackson persevered to achieve a Bachelor’s degree in Human Services, which landed him the perfect job.
Advances in the treatment of Multiple Sclerosis have been good news for patients, but side effects and risks mean that an active management strategy and constant monitoring are essential.
Griffith University is one of two Australian universities selected to host a United Nations (UN) 2023 Millennium Fellowship Class (MFC), designed to foster student-led projects which support Sustainable Development Goals (SDGs).
Two Griffith University research projects have been successful in gaining grants from the Medical Research Future Fund (MRFF) worth a combined $2.7 million.
Calls for more study to be conducted into how microorganisms contribute to the onset and progression of Alzheimer’s disease.
Calls for new national clinical guidelines to improve the care of hundreds of thousands of Australians with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and potentially thousands more with Long Covid.
Griffith University is paying tribute to one of its finest in Professor Emeritus Alan Mackay-Sim AM known to many as...
Healthcare rationing disproportionately affects people with disabilities and COVID-19 has put a well overdue spotlight on the issue.
The Griffith Sport MS Swimathon is taking the challenge in the pool to new heights this year with plans to...